Introduction: Diabetic ketoacidosispatients frequently develop a constellation of electrolyte disorders. These patientsare markedly potassium-, magnesium- and phosphate-depleted, but hypocalcemia due to transient hypoparathyroidism was seldom reported previously. Methods: We describe the clinical history, physical examination findings and laboratory values of the patient and briefly review the relevant literature.

Background and aims: A personal indirect calorimeter allows everyone to assess resting and non-resting energy expenditure, thus enabling accurate determination of a person’s total calorie need for weight management and fitness. The aim of this study is to compare the performance of a new personal metabolic rate tracker based on indirect calorimetry, Breezing®, with the Douglas bag method, the gold standard method for energy expenditure (EE) measurement.

Cardiovascular diseases are still one of the major causes of death for the people in the world. Biomedical implantable devices are the basic approach on the treatment of cardiovascular diseases. However, unexpected and serious complications can be observed in the case of their usage. Nanotechnology gives a promising perspective to overcome these drawbacks. Nanoparticulate drug delivery systems have develop superior medical solutions and offer better prospects to patients. This review comprehensively summarizes the recent situation, the benefits and the role of nanocarriers in cardiovascular implant technology.

We report clinical and molecular mechanisms relating the pro-inflammatory and anti-inflammatory process in the development of the components of the metabolic syndrome, emphasizing the cardiovascular problems developed in these groups of patients, especially the Hispanic population. Namely, the incidence, component characteristics and complications of the metabolic syndrome in island Puerto Ricans are described and evidence is presented supporting the fact that the metabolic syndrome may be milder in Puerto Rico than in the mainland United States because it is characterized by less aggressive coronary artery disease and a relatively normal lipid profile. Moreover, data supports the fact that increased serum cholesterol levels produce less myocardial infarctions in Puerto Rico than in mainland Hispanics and Caucasians. In addition, the incidence of ventricular tachycardia, a complication caused by remodeling and ischemia of the heart, may be lower in Puerto Rico than in the United States, although the prevalence of the metabolic syndrome is higher in the island.